Approach for classification and severity grading of long-term and late-onset health events among childhood cancer survivors in the St. Jude lifetime cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 5, 2017, Pages 666-674

  Hudson, Melissa M ^a   Ehrhardt, Matthew J ^a   Bhakta, Nickhill ^a   Baassiri, Malek ^a   Eissa, Hesham ^a   Chemaitilly, Wassim ^a   Green, Daniel M ^a   Mulrooney, Daniel A ^a   Armstrong, Gregory T ^a   Brinkman, Tara M ^a   Klosky, James L ^a   Krull, Kevin R ^a   Sabin, Noah D ^a   Wilson, Carmen L ^a   Huang, I Chan ^a   Bass, Johnnie K ^a   Hale, Karen ^a   Kaste, Sue ^a   Khan, Raja B ^a   Srivastava, Deo Kumar ^a   Yasui, Yutaka ^a   Joshi, Vijaya M ^b   Srinivasan, Saumini ^b   Stokes, Dennis ^b   Hoehn, Mary Ellen ^b   Wilson, Matthew ^b   Ness, Kirsten K ^a   Robison, Leslie L ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVERSE OUTCOME; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER RADIOTHERAPY; CHILDHOOD CANCER; CHILDHOOD CANCER SURVIVOR; CLINICAL ASSESSMENT; COHORT ANALYSIS; DISEASE SEVERITY; FOLLOW UP; HUMAN; LIFESPAN; LONGITUDINAL STUDY; MORBIDITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PATIENT-REPORTED OUTCOME; PRIORITY JOURNAL; REVIEW; ADOLESCENT; CANCER SURVIVOR; CHILD; CLASSIFICATION; COMPLICATION; NEOPLASM; RADIOTHERAPY; YOUNG ADULT;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CANCER SURVIVORS; CHILD; COHORT STUDIES; HUMANS; NEOPLASMS; RADIOTHERAPY; YOUNG ADULT;

EID: 85019243142     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0812     Document Type: Review

References (28)

1. Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev 2015;24:653-63.
2. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 2014;14:61-70.
3. Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 2016;374:833-42.
4. Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 2014; 32:1218-27.
5. Bhakta N, Liu Q, Yeo F, Baassiri M, Ehrhardt MJ, Srivastava DK, et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 2016;17:1325-34.
6. Fidler MM, Reulen RC, Winter DL, Kelly J, Jenkinson HC, Skinner R, et al. Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ 2016;354:i4351.
7. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007;297:2705-15.
8. HudsonMM,Ness KK, Gurney JG,Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013;309:2371-81.
9. Rebholz CE, Reulen RC, Toogood AA, Frobisher C, Lancashire ER, Winter DL, et al. Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 2011;29:4181-8.
10. CTEP. Cancer. gov [homepage on the internet]. Bethesda, MD: NCI; [updated 2016 Nov 14]. Available from: http://ctep. cancer. gov/protocol-Development/electronic-applications/ctc. htm#ctc-40.
11. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2. 0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13-47.
12. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-81.
13. Hudson MM, Ness KK, Nolan VG, Armstrong GT, Green DM, Morris EB, et al. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer 2011;56:825-36.
14. ISCD. org [homepage on the Internet]. Skeletal health assessment in children from infancy to adolescence. Fracture prediction and definition of osteoporosis. Middletown, CT: International Society for Clinical Densitometry; c2013 [updated 2014 Sep 2]. Available from: http://www. iscd. org/official-positions/2013-iscd-official-positions-pediatric/.
15. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. editors. International classification of diseases for oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2013. Available from: http:// apps. who. int/iris/bitstream/10665/96612/1/9789241548496-eng. pdf?ua1.
16. CMS. gov [homepage on the Internet]. ICD-9-CM diagnosis and procedure codes: abbreviated and full code titles. Baltimore, MD: Centers for Medicare & Medicaid Services; [updated 2014 May 20]. Available from: https://www. cms. gov/medicare/coding/ICD9providerdiagnosticcodes/ codes. html#.
17. de Rojas T, Bautista FJ, Madero L, Moreno L. The first step to integrating adapted Common Terminology Criteria for Adverse Events for children. J Clin Oncol 2016;34:2196-7.
18. Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, et al. Longterm outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009;101:946-58.
19. Brignardello E, Felicetti F, Castiglione A, Chiabotto P, Corrias A, Fagioli F, et al. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics. Eur J Endocrinol 2013;168:465-72.
20. Brinkman TM, Krasin MJ, Liu W, Armstrong GT, Ojha RP, Sadighi ZS, et al. Long-term neurocognitive functioning and social attainment in adult survivors of pediatric CNS tumors: results from the St Jude Lifetime Cohort Study. J Clin Oncol 2016;34:1358-67.
21. Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, et al. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study. J Clin Oncol 2015;33:492-500.
22. Krull KR, Brinkman TM, Li C, Armstrong GT, Ness KK, Srivastava DK, et al. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study. J Clin Oncol 2013;31:4407-15.
23. Krull KR, Cheung YT, Liu W, Fellah S, Reddick WE, Brinkman TM, et al. Chemotherapy pharmacodynamics and neuroimaging and neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 2016;34:2644-53.
24. Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Stovall M, et al. Endocrine abnormalities in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2016;34:3240-7.
25. Schuitema I, Deprez S, Van Hecke W, Daams M, Uyttebroeck A, Sunaert S, et al. Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol 2013;31:3378-88.
26. Brinkman TM, Li C, Vannatta K, Marchak JG, Lai JS, Prasad PK, et al. Behavioral, social, and emotional symptom comorbidities and profiles in adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2016;34: 3417-25.
27. Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, et al. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer 2016; 24:3669-76.
28. Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of theNational Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PROCTCAE). J Natl Cancer Inst 2014;106:1-11.